Literature DB >> 12182752

Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease.

R W Stockbrügger1, E J Schoon, S Bollani, P R Mills, E Israeli, L Landgraf, D Felsenberg, S Ljunghall, G Nygard, T Persson, H Graffner, G Bianchi Porro, A Ferguson.   

Abstract

BACKGROUND: A high prevalence of osteoporosis has been noted in Crohn's disease, but data about fractures are scarce.
METHODS: The relationship between low bone mineral density and the prevalence of vertebral fractures was studied in 271 patients with ileo-caecal Crohn's disease in a large European/Israeli study. One hundred and eighty-one currently steroid-free patients with active Crohn's disease (98 completely steroid-naive) and 90 steroid-dependent patients with inactive or quiescent Crohn's disease were investigated by dual X-ray absorptiometry scan of the lumbar spine, a standardized posterior/anterior and lateral X-ray of the thoracic and lumbar spine, and an assessment of potential risk factors for osteoporosis.
RESULTS: Thirty-nine asymptomatic fractures were seen in 25 of 179 steroid-free patients (14.0%; 27 wedge, 12 concavity), and 17 fractures were seen in 13 of 89 steroid-dependent patients (14.6%; 14 wedge, three concavity). The prevalence of fractures in steroid-naive patients was 12.4%. The average bone mineral density, expressed as the T-score, of patients with fractures was not significantly different from that of those without fractures (-0.759 vs. -0.837; P=0.73); 55% of patients with fractures had a normal T-score. The bone mineral density was negatively correlated with lifetime steroids, but not with previous bowel resection or current disease activity. The fracture rate was not correlated with the bone mineral density (P=0.73) or lifetime steroid dose (P=0.83); in women, but not in men, the fracture rate was correlated with age (P=0.009).
CONCLUSIONS: The lack of correlation between the prevalence of fractures on the one hand and the bone mineral density and lifetime steroid dose on the other necessitates new hypotheses for the pathogenesis of the former.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182752     DOI: 10.1046/j.1365-2036.2002.01317.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  18 in total

1.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 2.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Osteoporosis in adult Sri Lankan inflammatory bowel disease patients.

Authors:  Arjuna Priyadarsin de Silva; Aranjan Lionel Karunanayake; Thalahitiya Gamaralalage Iruka Dissanayaka; Anuradha Supun Dassanayake; Hewa Kattadi Kankanamgae Tilak Duminda; Arunasalam Pathmeswaran; Ananda Rajitha Wickramasinghe; Hithanadura Janaka de Silva
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

4.  Increased fracture risk assessed by fracture risk assessment tool in Greek patients with Crohn's disease.

Authors:  Sotirios Terzoudis; Christos Zavos; John Damilakis; John Neratzoulakis; Daphne Anna Dimitriadi; Maria Roussomoustakaki; Elias A Kouroumalis; Ioannis E Koutroubakis
Journal:  Dig Dis Sci       Date:  2012-08-03       Impact factor: 3.199

5.  Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.

Authors:  Stefano Palomba; Francesco Orio; Francesco Manguso; Angela Falbo; Tiziana Russo; Achille Tolino; Libuse Tauchmanovà; Annamaria Colao; Patrizia Doldo; Pasquale Mastrantonio; Fulvio Zullo
Journal:  Osteoporos Int       Date:  2005-06-01       Impact factor: 4.507

Review 6.  Inflammatory bowel diseases as secondary causes of osteoporosis.

Authors:  Charles N Bernstein
Journal:  Curr Osteoporos Rep       Date:  2006-09       Impact factor: 5.096

Review 7.  Chronic pediatric inflammatory diseases: effects on bone.

Authors:  Anuradha Viswanathan; Francisco A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2007-12-29       Impact factor: 6.514

8.  Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study.

Authors:  T Card; J West; R Hubbard; R F A Logan
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 9.  Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Authors:  Lorena Rodríguez-Bores; Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

10.  Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease.

Authors:  L M Ward; F Rauch; M A Matzinger; E I Benchimol; M Boland; D R Mack
Journal:  Osteoporos Int       Date:  2009-06-06       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.